Albertsons’ federal partnership to offer vaccines from the federal supply in five states joins efforts already underway to help states administer their vaccine allocations.
For its second quarter of fiscal 2020, Albertsons reported digital sales growth of 243%, identical-sales growth of 13.8% and revenue growth of 11.2% to $15.8 billion.
Albertsons partnered with genomics firm Phosphorus to begin offering at-home COVID-19 test kits in select markets, with plans to expand the offering throughout September and October.